Mackay Shields’s Cantel Medical CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-8,100
Closed -$647K – 1493
2021
Q1
$647K Buy
8,100
+5,100
+170% +$398K ﹤0.01% 1135
2020
Q4
$236K Buy
+3,000
New +$176K ﹤0.01% 1392

Mackay Shields's CMD Position: Q2 2021 in Review

Mackay Shields sold out of Cantel Medical (CMD) in Q2 2021, closing a stake of 8,100 shares — an estimated $647K sold.

Mackay Shields first reported a position in CMD in Q4 2020 and held it in 2 quarters. The position peaked at $647K in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • Mackay Shields reported no remaining Cantel Medical position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields sold 8,100 Cantel Medical shares in Q2 2021, an estimated $647K.
  • Mackay Shields first reported a position in Cantel Medical in Q4 2020 and held it in 2 quarters.
  • Mackay Shields's Cantel Medical position peaked at $647K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Cantel Medical as of Q2 2021.

Based on Mackay Shields's 13F filing for Q2 2021, filed 13 Aug 2021.